Mindfulness Group-based Intervention for Early Psychosis
Primary Purpose
Psychotic Disorders, Schizophrenia
Status
Completed
Phase
Not Applicable
Locations
Canada
Study Type
Interventional
Intervention
Mindfulness Ambassador Council for Early Psychosis (MAC-EP)
Sponsored by
About this trial
This is an interventional treatment trial for Psychotic Disorders focused on measuring Mindfulness, Group Therapy
Eligibility Criteria
Inclusion Criteria:
- Participants must currently be in treatment for psychosis at one of the five Early Psychosis Intervention (EPI) study sites. In addition, participants must have been involved in the program for a period of less than 3 years, due to the focus of this study being on the treatment of early psychosis. Participants must be fluent in English, as determined by referring clinicians or researchers (in the case of advertisement referred participants) in order to meaningfully participate in the MAC intervention and complete the assessment tools.
Exclusion Criteria:
- Potential participants that show high levels of disorganized or disruptive behaviour (as determined by a cut off score of 4 or 5 on the Positive Formal Thought Disorder or Bizarre Behaviour items of the Scale for the Assessment of Positive Symptoms [SAPS]) such that they will not be able to meaningfully participate in the MAC intervention will be excluded from the study.
Sites / Locations
- Canadian Mental Health Association Chatham-Kent Health Alliance
- Canadian Mental Health Association Wellington-Waterloo
- Cleghorn Early Psychosis Intervention Clinic
- Prevention and Early Intervention Program for Psychoses
- Canadian Mental Health Association Lambton-Kent
Arms of the Study
Arm 1
Arm 2
Arm Type
Other
Other
Arm Label
Group-A - Immediate Intervention
Group-B - Delayed Intervention
Arm Description
Immediate Mindfulness Ambassador Council for Early Psychosis (MAC-EP)
6 month treatment as usual waitlist followed by Mindfulness Ambassador Council for Early Psychosis (MAC-EP)
Outcomes
Primary Outcome Measures
Self-Evaluation of Negative Symptoms (SNS)
Self-report measure for the assessment of negative symptoms
Kentucky Inventory of Mindfulness Skills
Self-report measure of mindfulness skills
Secondary Outcome Measures
Rosenberg Self-Esteem Scale (RSES)
self-report measure of self-esteem
Profile of Mood States - Short Form (POMS-SF)
self-report measure of mood
World Health Organization Quality of Life Scale - Brief version (WHOQOL-BREF)
self-report measure of quality of life
Ways of Coping Questionnaire (WCQ)
self-report measure of ways to cope
Cognitive Failures Questionnaire (CFQ)
self-report measure of cognitive failures
Rathus Assertiveness Scale (RAS)
self-report measure of assertiveness
Health Care Utilization Records Post-Intervention
form to document participant health care utilization
Kentucky Inventory of Mindfulness Skills (KIMS)
self-report measure of mindfulness skills
Maryland Assessment of Recovery in People With Serious Mental Illness (MAR)
self-report measure of perceived self-recovery
First-Episode Social Functioning Scale (FESFS)
self-report measure of social functioning
Full Information
NCT ID
NCT03143907
First Posted
May 4, 2017
Last Updated
September 22, 2020
Sponsor
Lawson Health Research Institute
Collaborators
University of Western Ontario, Canada, London Health Sciences Centre, Mindfulness Without Borders
1. Study Identification
Unique Protocol Identification Number
NCT03143907
Brief Title
Mindfulness Group-based Intervention for Early Psychosis
Official Title
Mindfulness Group-based Intervention for Early Psychosis: A Multi-Site Randomized Control Trial
Study Type
Interventional
2. Study Status
Record Verification Date
September 2020
Overall Recruitment Status
Completed
Study Start Date
February 22, 2018 (Actual)
Primary Completion Date
May 31, 2020 (Actual)
Study Completion Date
May 31, 2020 (Actual)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Lawson Health Research Institute
Collaborators
University of Western Ontario, Canada, London Health Sciences Centre, Mindfulness Without Borders
4. Oversight
Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No
5. Study Description
Brief Summary
Recent research has suggested that mindfulness-based interventions (MBI) for psychosis may be effective in reducing the negative symptoms of schizophrenia (e.g., social withdrawal, lack of motivation) and the distress associated with psychotic symptoms (e.g., hearing voices) and could lead to improvements in functioning and quality of life. MBI research to date has primarily focused on studies of patients with chronic psychotic illness, yet relatively little is known about the use of MBIs for youth recovering from their first episode of psychosis. Results from recently published pilot studies appear promising in terms of the feasibility, acceptability, and potential clinical utility (e.g., improved psychological symptoms) of MBIs for the early psychosis population (Ashcroft et al., 2012; van der Valk et al., 2013; Khoury et al., 2015). The current project team has completed a pilot study at the Prevention and Early Intervention Program for Psychoses (PEPP) at London Health Sciences Centre (LHSC), wherein the "Mindfulness Ambassador Council" (MAC), a 12-week facilitated group intervention promoting mindfulness skills and the development of emotional and social competencies, was shown to be an effective, feasible, and acceptable means of treating youth in the early stages of psychotic illnesses. In follow up to the initial pilot study, the purpose of this study is to perform a multi-site Randomized Control Trial to determine the effectiveness of the MAC group intervention on reducing psychotic disorder symptomatology for transitional aged youth experiencing early psychosis. The main hypothesis, based on previous findings on the use of MBIs in psychotic disorders, including results from our initial pilot study at PEPP, is that people with early psychosis who participate in the MAC group intervention will experience improvement in mindfulness skills and affective symptoms compared to those receiving treatment as usual (TAU). Furthermore, we expect that people experiencing early psychosis who participate in MAC will have an improvement in their negative symptoms, quality of life, recovery (self-esteem, perceived recovery), perceived coping, assertiveness, social functioning, and cognitive skills, and a reduction in healthcare service utilization (e.g., emergency room visits, inpatient admissions/length of hospitalization).
Detailed Description
The purpose of this multi-site RCT is to determine the effectiveness of the MAC group intervention on reducing psychotic disorder symptomatology (primary outcome) as well as promoting quality of life, critical skills for recovery and decreasing mental health service utilization (secondary outcomes) for transitional aged youth (16-25 years old) experiencing early psychosis. This study is being run at five southern Ontario Early Psychosis Intervention (EPI) sites with Prevention and Early Intervention Program for Psychoses (PEPP) at London Health Sciences Centre (LHSC) being the lead site. Three of the larger sites (located in London, Kitchener-Waterloo, and Hamilton Ontario) are following the RCT design, while the two smaller sites (located in Chatham-Kent and Sarnia, Ontario) are participating in a pre-post design.
For the three RCT sites we aim to recruit 20-24 participants, and for the pre-post sites we aim to recruit 10 participants (total n=92 participants). Participants at the RCT sites will be randomized into Group-A (n = 12; immediate treatment intervention group) or Group-B (n = 12; delayed treatment intervention group). Group-A will receive the MAC intervention at the onset of the study, while Group-B will receive treatment as usual (TAU). Group-B will have the option of receiving the MAC intervention approximately 6 months after the onset of the study. At all times during this study, participants who are receiving the MAC intervention will also be able to continue receiving TAU. Both groups will be assessed with a battery of quantitative measures at baseline (T1), three months later (i.e., immediately post-MAC intervention) (T2), and again three months post-MAC intervention (T3). The measures include interview assessments of psychotic disorder symptoms, and self-report measures of affect, self-esteem, quality of life, coping strategies, assertiveness, social functioning, mindfulness and cognitive skills. In addition, healthcare utilization records for the 6 months preceding MAC intervention onset and for the 6 month duration of the study (3 month MAC intervention + 3 month post-MAC intervention follow-up period) will be collected. Researchers conducting symptom assessment interviews and data analysis will be blinded to the group membership of participants. For the two pre-post sites, all 10 participants will receive the MAC intervention immediately. All 10 participants will complete T1, T2, and T3 assessments and their healthcare utilization records will also be collected.
Based on the pilot study at PEPP-LHSC, and based on previous findings of Mindfulness Based Interventions for psychoses in the literature, we are expecting that participation in the MAC intervention will result in improvement in the following areas: psychotic symptomology (including affective symptoms), mindfulness skills, quality of life, measures of recovery (self-esteem, perceived recovery), perceived coping, assertiveness, social functioning, cognitive skills, and a reduction in healthcare service utilization (e.g., emergency room visits, inpatient admissions/length of hospitalization).
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Psychotic Disorders, Schizophrenia
Keywords
Mindfulness, Group Therapy
7. Study Design
Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Model Description
Five sites in total are participating. Three of the five sites are following a RCT design (randomized group allocation; treatment and control group). Two of the five sites are following a pre-post design (no randomized allocation and no control group).
Masking
Outcomes Assessor
Allocation
Randomized
Enrollment
70 (Actual)
8. Arms, Groups, and Interventions
Arm Title
Group-A - Immediate Intervention
Arm Type
Other
Arm Description
Immediate Mindfulness Ambassador Council for Early Psychosis (MAC-EP)
Arm Title
Group-B - Delayed Intervention
Arm Type
Other
Arm Description
6 month treatment as usual waitlist followed by Mindfulness Ambassador Council for Early Psychosis (MAC-EP)
Intervention Type
Behavioral
Intervention Name(s)
Mindfulness Ambassador Council for Early Psychosis (MAC-EP)
Intervention Description
MAC is a 12-week facilitated group mindfulness intervention promoting the development of social-emotional competence in youth created by Mindfulness Without Borders (MWB; www.mwb.org). A meditative practice, mindfulness focuses one's awareness on the present, acknowledging and accepting without judging one's feelings, thoughts, or bodily sensations. Each session has a unique focus (e.g., paying attention, practicing gratitude) and consists of facilitated group learning, discussion and mindfulness skills practice. Home assignments to help reinforce specific lesson are also assigned. MAC has demonstrated acceptability, feasibility, and promising beneficial effects in schools, and in the pilot study conducted at the Early Psychosis Program at London Health Sciences Centre in London, Ontario. Its youth-focus and emphasis on building social and emotional competencies through mindfulness make it a promising intervention for youth recovering from their first episode of psychosis.
Primary Outcome Measure Information:
Title
Self-Evaluation of Negative Symptoms (SNS)
Description
Self-report measure for the assessment of negative symptoms
Time Frame
Baseline, change from Baseline in SNS at 3 months, change from Baseline in SNS at 6 months
Title
Kentucky Inventory of Mindfulness Skills
Description
Self-report measure of mindfulness skills
Time Frame
Baseline, change from Baseline in KIMS at 3 months, change from Baseline in KIMS at 6 months
Secondary Outcome Measure Information:
Title
Rosenberg Self-Esteem Scale (RSES)
Description
self-report measure of self-esteem
Time Frame
Baseline, change from Baseline in RSES at 3 months, change from Baseline in RSES at 6 months
Title
Profile of Mood States - Short Form (POMS-SF)
Description
self-report measure of mood
Time Frame
Baseline, change from Baseline in POMS-SF at 3 months, change from Baseline in POMS-SF at 6 months
Title
World Health Organization Quality of Life Scale - Brief version (WHOQOL-BREF)
Description
self-report measure of quality of life
Time Frame
Baseline, change from Baseline in WHOQOL at 3 months, change from Baseline in WHOQOL at 6 months
Title
Ways of Coping Questionnaire (WCQ)
Description
self-report measure of ways to cope
Time Frame
Baseline, change from Baseline in WCQ at 3 months, change from Baseline in WCQ at 6 months
Title
Cognitive Failures Questionnaire (CFQ)
Description
self-report measure of cognitive failures
Time Frame
Baseline, change from Baseline in CFQ at 3 months, change from Baseline in CFQ at 6 months
Title
Rathus Assertiveness Scale (RAS)
Description
self-report measure of assertiveness
Time Frame
Baseline, change from Baseline in RAS at 3 months, change from Baseline in RAS at 6 months
Title
Health Care Utilization Records Post-Intervention
Description
form to document participant health care utilization
Time Frame
Utilization at Baseline and during the 6 months following the mindfulness intervention
Title
Kentucky Inventory of Mindfulness Skills (KIMS)
Description
self-report measure of mindfulness skills
Time Frame
Baseline, change from Baseline in KIMS at 3 months, change from Baseline in KIMS at 6 months
Title
Maryland Assessment of Recovery in People With Serious Mental Illness (MAR)
Description
self-report measure of perceived self-recovery
Time Frame
Baseline, change from Baseline in MAR at 3 months, change from Baseline in MAR at 6 months
Title
First-Episode Social Functioning Scale (FESFS)
Description
self-report measure of social functioning
Time Frame
Baseline, change from Baseline in FESFS at 3 months, change from Baseline in FESFS at 6 months
10. Eligibility
Sex
All
Minimum Age & Unit of Time
16 Years
Maximum Age & Unit of Time
35 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
Participants must currently be in treatment for psychosis at one of the five Early Psychosis Intervention (EPI) study sites. In addition, participants must have been involved in the program for a period of less than 3 years, due to the focus of this study being on the treatment of early psychosis. Participants must be fluent in English, as determined by referring clinicians or researchers (in the case of advertisement referred participants) in order to meaningfully participate in the MAC intervention and complete the assessment tools.
Exclusion Criteria:
Potential participants that show high levels of disorganized or disruptive behaviour (as determined by a cut off score of 4 or 5 on the Positive Formal Thought Disorder or Bizarre Behaviour items of the Scale for the Assessment of Positive Symptoms [SAPS]) such that they will not be able to meaningfully participate in the MAC intervention will be excluded from the study.
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Arlene MacDougall, M.Sc. M.D.
Organizational Affiliation
University of Western Ontario/London Health Sciences Centre
Official's Role
Principal Investigator
Facility Information:
Facility Name
Canadian Mental Health Association Chatham-Kent Health Alliance
City
Chatham
State/Province
Ontario
ZIP/Postal Code
N7L 1C1
Country
Canada
Facility Name
Canadian Mental Health Association Wellington-Waterloo
City
Guelph
State/Province
Ontario
ZIP/Postal Code
N1H 0A1
Country
Canada
Facility Name
Cleghorn Early Psychosis Intervention Clinic
City
Hamilton
State/Province
Ontario
ZIP/Postal Code
L9C 0E3
Country
Canada
Facility Name
Prevention and Early Intervention Program for Psychoses
City
London
State/Province
Ontario
ZIP/Postal Code
N6A 5W9
Country
Canada
Facility Name
Canadian Mental Health Association Lambton-Kent
City
Sarnia
State/Province
Ontario
ZIP/Postal Code
N7T 4C7
Country
Canada
12. IPD Sharing Statement
Citations:
PubMed Identifier
23796855
Citation
Khoury B, Lecomte T, Fortin G, Masse M, Therien P, Bouchard V, Chapleau MA, Paquin K, Hofmann SG. Mindfulness-based therapy: a comprehensive meta-analysis. Clin Psychol Rev. 2013 Aug;33(6):763-71. doi: 10.1016/j.cpr.2013.05.005. Epub 2013 Jun 7.
Results Reference
background
PubMed Identifier
25818837
Citation
Khoury B, Sharma M, Rush SE, Fournier C. Mindfulness-based stress reduction for healthy individuals: A meta-analysis. J Psychosom Res. 2015 Jun;78(6):519-28. doi: 10.1016/j.jpsychores.2015.03.009. Epub 2015 Mar 20.
Results Reference
background
PubMed Identifier
21976710
Citation
Bell MD, Corbera S, Johannesen JK, Fiszdon JM, Wexler BE. Social cognitive impairments and negative symptoms in schizophrenia: are there subtypes with distinct functional correlates? Schizophr Bull. 2013 Jan;39(1):186-96. doi: 10.1093/schbul/sbr125. Epub 2011 Oct 5.
Results Reference
background
PubMed Identifier
9764127
Citation
Birchwood M, Todd P, Jackson C. Early intervention in psychosis. The critical period hypothesis. Br J Psychiatry Suppl. 1998;172(33):53-9.
Results Reference
background
PubMed Identifier
23616779
Citation
Shonin E, Van Gordon W, Griffiths MD. Mindfulness-based interventions: towards mindful clinical integration. Front Psychol. 2013 Apr 18;4:194. doi: 10.3389/fpsyg.2013.00194. eCollection 2013. No abstract available.
Results Reference
background
PubMed Identifier
24220133
Citation
Shonin E, Van Gordon W, Griffiths MD. Do mindfulness-based therapies have a role in the treatment of psychosis? Aust N Z J Psychiatry. 2014 Feb;48(2):124-7. doi: 10.1177/0004867413512688. Epub 2013 Nov 12. No abstract available.
Results Reference
background
PubMed Identifier
21549566
Citation
Norman RM, Manchanda R, Malla AK, Windell D, Harricharan R, Northcott S. Symptom and functional outcomes for a 5 year early intervention program for psychoses. Schizophr Res. 2011 Jul;129(2-3):111-5. doi: 10.1016/j.schres.2011.04.006. Epub 2011 May 5.
Results Reference
background
Citation
Chambers R, Lo BCY, Allen NB. The impact of intensive mindfulness training on attentional control, cognitive style and affect. Cognitive Therapy & Research 32: 303-322, 2008.
Results Reference
background
PubMed Identifier
17099070
Citation
Buchanan RW. Persistent negative symptoms in schizophrenia: an overview. Schizophr Bull. 2007 Jul;33(4):1013-22. doi: 10.1093/schbul/sbl057. Epub 2006 Nov 10.
Results Reference
background
PubMed Identifier
25329321
Citation
Tan LB, Lo BC, Macrae CN. Brief mindfulness meditation improves mental state attribution and empathizing. PLoS One. 2014 Oct 17;9(10):e110510. doi: 10.1371/journal.pone.0110510. eCollection 2014.
Results Reference
background
PubMed Identifier
15819448
Citation
Wenk-Sormaz H. Meditation can reduce habitual responding. Altern Ther Health Med. 2005 Mar-Apr;11(2):42-58.
Results Reference
background
PubMed Identifier
20363650
Citation
Zeidan F, Johnson SK, Diamond BJ, David Z, Goolkasian P. Mindfulness meditation improves cognition: evidence of brief mental training. Conscious Cogn. 2010 Jun;19(2):597-605. doi: 10.1016/j.concog.2010.03.014. Epub 2010 Apr 3.
Results Reference
background
PubMed Identifier
19545481
Citation
Chadwick P, Hughes S, Russell D, Russell I, Dagnan D. Mindfulness groups for distressing voices and paranoia: a replication and randomized feasibility trial. Behav Cogn Psychother. 2009 Jul;37(4):403-12. doi: 10.1017/S1352465809990166. Epub 2009 Jun 23.
Results Reference
background
PubMed Identifier
27146475
Citation
Chadwick P, Strauss C, Jones AM, Kingdon D, Ellett L, Dannahy L, Hayward M. Group mindfulness-based intervention for distressing voices: A pragmatic randomised controlled trial. Schizophr Res. 2016 Aug;175(1-3):168-173. doi: 10.1016/j.schres.2016.04.001. Epub 2016 Apr 14.
Results Reference
background
Links:
URL
http://www.nimh.nih.gov/health/topics/schizophrenia/raise/nimh-white-paper-csc-for-fep_147096.pdf
Description
Heinssen, R.K., Goldstein, A.B., & Azrin, S.T. (2014). Evidence-Based Treatments for First Episode Psychosis: Components of Coordinated Specialty Care. Recovery After An Initial Schizophrenia Episode (RA1SE).
URL
http://www.mwb.org
Description
Mindfulness Without Borders
Learn more about this trial
Mindfulness Group-based Intervention for Early Psychosis
We'll reach out to this number within 24 hrs